International Journal of Clinical and Diagnostic Pathology

International Journal of Clinical and Diagnostic Pathology

Login    Signup
Printed Journal   |   Indexed Journal   |   Refereed Journal   |   Peer Reviewed Journal

Vol. 6 Issue 2 Part B

2023, Vol. 6 Issue 2, Part BPages: 87-89

Gastrointestinal stromal tumour-sclerosing epithelioid a rare variant: A case report

Rajinder Singh, Yasmin Muhammed, Ajay Shanker Sharma and Jasbir Singh
Viewed: 323  -  Downloaded: 104
ABSTRACT
Gastrointestinal stromal tumours are the most common mesenchymal neoplasms of the gastrointestinal tract. They should be differentiated from other types of mesenchymal tumours. GISTs harbour specific activating mutations in the KIT or platelet-derived growth factor receptor a (PDGFRA) receptor tyrosine kinases, which makes them responsive to pharmacologic inhibitors. The advances in the identification of GISTs, by its molecular and immunohistochemical basis, have led to a better understanding of the rare gastrointestinal tract tumours with predictable behaviour and outcome, replacing the older terminologies like leiomyoma, schwannoma or leiomyosarcoma. This report presents a case of 64 yr. old male recently operated on for a rare sclerosing epithelioid variant of the gastrointestinal tumour.


International Journal of Clinical and Diagnostic Pathology
How to cite this article:
Rajinder Singh, Yasmin Muhammed, Ajay Shanker Sharma, Jasbir Singh. Gastrointestinal stromal tumour-sclerosing epithelioid a rare variant: A case report. Int J Clin Diagn Pathol 2023;6(2):87-89. DOI: 10.33545/pathol.2023.v6.i2b.522
Related Journal Subscription
International Journal of Clinical and Diagnostic Pathology

International Journal of Clinical and Diagnostic Pathology

International Journal of Clinical and Diagnostic Pathology
Call for book chapter